Research Solutions doubles profit while analysts rate Research Solutions stock Moderate Buy

Published on 10/05/2026 at 01:17 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

MarketBeat cites three Buy ratings and two Holds for Research Solutions stock. Fiscal 2026 revenue fell 1.53 percent to USD 48.31 million.

RSSS, US7610251057, Illustration mit AI erstellt.

Research Solutions (ISIN US7610251057) reported fiscal 2026 net income of USD 2.82 million, up 123.00 percent from USD 1.27 million a year earlier, while MarketBeat reported a Moderate Buy consensus on September 20, 2026. The results were released on September 9, 2026, by PR Newswire.

Profit rises as revenue softens

The fiscal year ended June 30, 2026, produced revenue of USD 48.31 million, down 1.53 percent from USD 49.06 million in fiscal 2025. The contraction came mainly from transaction revenue, which fell 8.70 percent to USD 27.49 million, while platform subscription revenue rose 9.80 percent to USD 20.82 million, according to PR Newswire.

That mix shift improved gross profit to USD 25.07 million from USD 24.20 million and lifted the gross margin to 51.90 percent from 49.30 percent. Adjusted EBITDA, a non-GAAP measure, increased 10.60 percent to USD 5.83 million, while operating cash flow declined to USD 5.27 million from USD 7.02 million.

Recurring revenue becomes the key test

Annual recurring revenue reached USD 22.55 million at June 30, 2026, an increase of 7.80 percent from USD 20.92 million a year earlier. B2B ARR rose 14.10 percent to USD 16.20 million, including USD 0.80 million of AI-related ARR, while B2C ARR declined 5.60 percent to USD 6.34 million.

The figures show a sharper split inside the business: subscription platforms are growing and carrying higher margins, while transaction activity is shrinking. Research Solutions also ended fiscal 2026 with USD 12.63 million in cash, compared with USD 12.23 million a year earlier, giving the recurring-revenue transition a measurable balance-sheet base.

Analysts see a higher valuation

MarketBeat said on September 20, 2026, that three analysts rated Research Solutions a Buy and two assigned a Hold. The average 12-month price target was USD 3.83, compared with the USD 2.07 market price cited in that report, while the finance quote for October 2, 2026, showed market capitalization of USD 71.9 million.

The consensus view therefore rests on execution rather than revenue acceleration alone. Investors are weighing the 123.00 percent increase in annual net income against the 1.53 percent revenue decline and the 8.70 percent drop in transaction revenue.

Last completed close stays at EUR 1.91

The last completed Lang & Schwarz close was EUR 1.91 on October 2, 2026. The stock's Nasdaq Capital Market listing and the euro close provide separate reference points for German investors, while the fiscal 2026 results supply the more important operating comparison.